{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T16:31:28Z","timestamp":1748968288075},"reference-count":23,"publisher":"Pharmaceutical Society of Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2024,2,8]]},"DOI":"10.1248\/bpb.b23-00659","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T22:13:27Z","timestamp":1707344007000},"page":"389-393","source":"Crossref","is-referenced-by-count":2,"title":["Possible Involvement of Protein Binding Inhibition in Changes in Dexmedetomidine Concentration in Extracorporeal Circuits during Midazolam Use"],"prefix":"10.1248","volume":"47","author":[{"given":"Keishi","family":"Yamasaki","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Sojo University"},{"name":"DDS Research Institute, Faculty of Pharmaceutical Sciences, Sojo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Tokuno","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Sojo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Tsukigawa","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Sojo University"},{"name":"DDS Research Institute, Faculty of Pharmaceutical Sciences, Sojo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Nagatsuka","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Nishi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Sojo University"},{"name":"DDS Research Institute, Faculty of Pharmaceutical Sciences, Sojo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Otagiri","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Sojo University"},{"name":"DDS Research Institute, Faculty of Pharmaceutical Sciences, Sojo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhki","family":"Sato","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Dallefeld SH, Sherwin J, Zimmerman KO, Watt KM. Dexmedetomidine extraction by the extracorporeal membrane oxygenation circuit: results from an <i>in vitro<\/i> study. <i>Perfusion<\/i>, <b>35<\/b>, 209\u2013216 (2020).","DOI":"10.1177\/0267659119868062"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Shekar K, Roberts JA, Mcdonald CI, Ghassabian S, Anstey C, Wallis SC, Mullany DV, Fung YL, Fraser JF. Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an <i>ex vivo<\/i> study. <i>Crit. Care<\/i>, <b>19<\/b>, 164 (2015).","DOI":"10.1186\/s13054-015-0891-z"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Michihara A, Hanada M, Nagatsuka (Handa) Y, Mizoguchi T, Ohchi Y, Sato Y. Change of dexmedetomidine and midazolam concentrations by simultaneous injection in an <i>in vitro<\/i> extracorporeal circuit. <i>Perfusion<\/i>, 02676591231184715 (2023).","DOI":"10.1177\/02676591231184715"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Otagiri M. A molecular functional study on the interactions of drugs with plasma proteins. <i>Drug Metab. Pharmacokinet.<\/i>, <b>20<\/b>, 309\u2013323 (2005).","DOI":"10.2133\/dmpk.20.309"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) He XM, Carter DC. Atomic structure and chemistry of human serum albumin. <i>Nature<\/i>, <b>358<\/b>, 209\u2013215 (1992).","DOI":"10.1038\/358209a0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Yamasaki K, Chuang VT, Maruyama T, Otagiri M. Albumin-drug interaction and its clinical implication. <i>Biochim. Biophys. Acta<\/i>, <b>1830<\/b>, 5435\u20135443 (2013).","DOI":"10.1016\/j.bbagen.2013.05.005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Fanali G, di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P. Human serum albumin: from bench to bedside. <i>Mol. Aspects Med.<\/i>, <b>33<\/b>, 209\u2013290 (2012).","DOI":"10.1016\/j.mam.2011.12.002"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Nishi K, Ono T, Nakamura T, Fukunaga N, Izumi M, Watanabe H, Suenaga A, Maruyama T, Yamagata Y, Curry S, Otagiri M. Structural insights into differences in drug-binding selectivity between two forms of human \u03b11-acid glycoprotein genetic variants, the A and F1*S forms. <i>J. Biol. Chem.<\/i>, <b>286<\/b>, 14427\u201314434 (2011).","DOI":"10.1074\/jbc.M110.208926"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Sch\u00f6nfeld DL, Ravelli RBG, Mueller U, Skerra A. The 1.8-\u00c5 crystal structure of \u03b1<sub>1<\/sub>-acid glycoprotein (Orosomucoid) solved by UV RIP reveals the broad drug-binding activity of this human plasma lipocalin. <i>J. Mol. Biol.<\/i>, <b>384<\/b>, 393\u2013405 (2008).","DOI":"10.1016\/j.jmb.2008.09.020"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Maruyama T, Otagiri M, Takadate A. Characterization of drug binding sites on \u03b1<sub>1<\/sub>-acid glycoprotein. <i>Chem. Pharm. Bull.<\/i>, <b>38<\/b>, 1688\u20131691 (1990).","DOI":"10.1248\/cpb.38.1688"},{"key":"11","unstructured":"11) Khan SN, Islam B, Khan AU. Probing midazolam interaction with human serum albumin and its effect on structural state of protein. <i>Int. J. Integr. Biol.<\/i>, <b>1<\/b>, 102\u2013112 (2007)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Bhattacharya AA, Curry S, Franks NP. Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures. <i>J. Biol. Chem.<\/i>, <b>275<\/b>, 38731\u201338738 (2000).","DOI":"10.1074\/jbc.M005460200"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Ohmori J, Maeda S, Higuchi H, Ishii M, Arai Y, Tomoyasu Y, Kohjitani A, Shimada M, Miyawaki T. Propofol increases the rate of albumin-unbound free midazolam in serum albumin solution. <i>J. Anesth.<\/i>, <b>25<\/b>, 618\u2013620 (2011).","DOI":"10.1007\/s00540-011-1176-6"},{"key":"14","unstructured":"14) Kragh-Hansen U. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands. <i>Mol. Pharmacol.<\/i>, <b>34<\/b>, 160\u2013171 (1988)."},{"key":"15","unstructured":"15) Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin. <i>Pharmacol. Rev.<\/i>, <b>33<\/b>, 17\u201353 (1981)."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Woolfork AG, Suh K, Weigand M, Hage DS. Studies of binding by 2-imidazolines to human serum albumin and alpha1-acid glycoprotein by high-performance affinity chromatography. <i>J. Pharm. Biomed. Anal.<\/i>, <b>202<\/b>, 114135 (2021).","DOI":"10.1016\/j.jpba.2021.114135"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Van der Maaten JMAA, Epema AH, Gallandat Huet RCG, Hennis PJ. The effect of midazolam at two plasma concentrations on hemodynamics and sufentanil requirement in coronary artery surgery. <i>J. Cardiothorac. Vasc. Anesth.<\/i>, <b>10<\/b>, 356\u2013363 (1996).","DOI":"10.1016\/S1053-0770(96)80097-8"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Miyoshi T, Yamamichi R, Maruyama T, Otagiri M. Reversal of signs of induced cotton effects of dicumarol-\u03b1<sub>1<\/sub>-acid glycoprotein systems by phenothiazine neuroleptics through ternary complexation. <i>Pharm. Res.<\/i>, <b>9<\/b>, 845\u2013849 (1992).","DOI":"10.1016\/0006-2952(92)90175-I"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Miyoshi T, Yamamichi R, Maruyama T, Takadate A, Otagiri M. Further characterization of reversal of signs of induced Cotton effects of dicumarol derivatives-\u03b11-acid glycoprotein systems by protriptyline. <i>Biochem. Pharmacol.<\/i>, <b>43<\/b>, 2161\u20132167 (1992).","DOI":"10.1016\/0006-2952(92)90175-I"},{"key":"20","unstructured":"20) Peters T. <i>All About Albumin: Biochemistry, Genetics, and Medical Applications<\/i>. Academic Press, San Diego, California (1995)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Udy AA, Roberts JA, Lipman J. <i>Antibiotic Pharmacokinetic\/Pharmacodynamic Considerations in the Critically Ill<\/i>. Springer, Singapore (2017).","DOI":"10.1007\/978-981-10-5336-8"},{"key":"22","unstructured":"22) Kremer JM, Wilting J, Janssen LH. Drug binding to human alpha-1-acid glycoprotein in health and disease. <i>Pharmacol. Rev.<\/i>, <b>40<\/b>, 1\u201347 (1988)."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Chuang VT, Otagiri M. Photoaffinity labeling of plasma proteins. <i>Molecules<\/i>, <b>18<\/b>, 13831\u201313859 (2013).","DOI":"10.3390\/molecules181113831"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/47\/2\/47_b23-00659\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:55:30Z","timestamp":1715576130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/47\/2\/47_b23-00659\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,8]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b23-00659","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,8]]},"article-number":"b23-00659"}}